Hypertension genomics and cardiovascular prevention
- PMID: 30211179
- PMCID: PMC6123211
- DOI: 10.21037/atm.2018.06.34
Hypertension genomics and cardiovascular prevention
Abstract
Hypertension continues to be a major risk factor for global mortality, and recent genome-wide association studies (GWAS) have expanded in size, leading to the identification of further genetic loci influencing blood pressure. In light of the new knowledge from the largest cardiovascular GWAS to date, we review the potential impact of genomics on discovering potential drug targets, risk stratification with genetic risk scores, drug selection with pharmacogenetics, and exploring insights provided by gene-environment interactions.
Keywords: Hypertension; cardiovascular disease; gene-environment; genetics; pharmacogenetics; risk score.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
References
-
- Evangelou E, Warren HR, Mosen-Ansorena D, et al. Genetic analysis of over one million people identifies 535 novel loci for blood pressure. bioRxiv 2017. Available online: https://www.biorxiv.org/content/early/2017/10/11/198234
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources